Teligent Opens Product Development Lab in Estonia
News Oct 14, 2016
Teligent Inc has announced that it has opened a pharmaceutical Product Development laboratory in Estonia. The GMP-compliant lab will support the development of topical and injectable pharmaceutical products for the company's North American markets.
The 3,000-square foot facility also includes administrative space for quality assurance and supply chain employees who oversee the company's third-party contract manufacturing activities around the world.
"We are excited to strengthen our R&D capabilities through the opening of this product development lab in Estonia," commented Jason Grenfell-Gardner, President and CEO of the Company. "We are impressed by the caliber of scientific talent available in the country, and look forward to this lab working closely with our R&D colleagues in New Jersey.''
The Company established its operation in Estonia in 2015, where it has been managing logistics and supply relationships between third-party suppliers and the US and Canadian markets. Grenfell-Gardner concluded, ''The opening of this lab for analytical method and formulation work is the next step in our journey to build pharmaceutical capabilities in our Estonia business.''
Sartorius Stedim Biotech and Siemens Sign Automation AgreementNews
Siemens becomes a preferred supplier for automation solutions. Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future.READ MORE
Cocaine Use Alters Gene Expression in Brain Reward CircuitsNews
A study in Biological Psychiatry investigates transcriptome-wide alterations in response to cocaine self-administration in mice.
Ipsen and MD Anderson Announce Bench-to-Bedside Cancer Drug Development PartnershipNews
MD Anderson will progress the drug candidate through Phase I clinical development with Ipsen being responsible for further global development and commercialization.READ MORE
Comments | 0 ADD COMMENT
10th Annual Congress on Drug Formulation & Analytical Techniques
Sep 03 - Sep 04, 2018